We consider an automated processing pipeline for tissue micro array analysis (TMA) of renal cell carcinoma. It consists of several consecutive tasks, which can be mapped to machine learning challenges. We investigate three of these tasks, namely nuclei segmentation, nuclei classification and staining estimation. We argue for a holistic view of the processing pipeline, as it is not obvious whether performance improvements at individual steps improve overall accuracy. The experimental results show that classification accuracy, which is comparable to trained human experts, can be achieved by using support vector machines (SVM) with appropriate kernels. Furthermore, we provide evidence that the shape of cell nuclei improves classification performance. Most importantly, we demonstrate that these improvements in classification accuracy result in corresponding improvements for medically relevant task of immunohistochemical staining estimation. Cancer tissue analysis consists of several consecutive estimation and classification steps which are currently highly labour intensive. The tissue microarray (TMA) technology promises to significantly accelerate studies seeking for associ-
. TMA processing pipeline, consisting of the following stages: (1) Detection of cell nuclei within a high resolution TMA image, (2) nuclei segmentation, (3) nuclei classification into malignant and benign, and (4) calculation of the percentage of tumor cells and protein expressing tumor cells. The pathologists directly assign a staining score (pale dashed arrow). We consider the subset of tasks indicated by the boxed region.
Cancer tissue analysis consists of several consecutive estimation and classification steps which are currently highly labour intensive. The tissue microarray (TMA) technology promises to significantly accelerate studies seeking for associ-ations between molecular changes and clinical endpoints [2] . In this technology, 0.6mm tissue cylinders are punched from primary tumor blocks of hundreds of different patients and these cylinders are subsequently embedded into a recipient tissue block. Sections from such array blocks can then be used for simultaneous in situ analysis of hundreds or thousands of primary tumors on DNA, RNA, and protein level.
This work investigates an automated system to model such a workflow for renal cell carcinoma (RCC). Current image analysis software requires extensive user interaction to properly identify cell populations, to select regions of interest for scoring, to optimize analysis parameters and to organize the resulting raw data. Due to these drawbacks in current software, pathologists typically collect tissue microarray data by manually assigning a composite staining score for each spot -often during multiple microscopy sessions over a period of days. Such manual scoring can result in serious inconsistencies between data collected during different microscopy sessions. Manual scoring also introduces a significant bottleneck that hinders the use of tissue microarrays in high-throughput analysis.
The manual rating and assessment of TMAs under the microscope by pathologists is quite error prone due to the subjective perception of humans. In fact, one pathologist might differ in the detection and classification of the same cell nuclei within the same image in a second attempt [1] . Therefore, decisions for grading and/or cancer therapy might be inconsistent among pathologists.
In this work, we follow the workflow in [1] which consists of cell nuclei detection, segmentation and classification, followed by estimation of the proportion of nuclei stained by the antibody under investigation (Figure 1 ). In particular, we investigate the effect of different image features and kernels on the accuracy of classifying whether a cell nucleus is cancerous or not. By considering the different types of features, we show the importance of using shape features. The effect of classification accuracy on staining estimation is also shown. Our contribution in this paper includes a comprehensive investigation of various image features and associated kernels on the performance of a support vector machine classifier for cancerous cells. Since the classifier is only a part of a larger pipeline, we show that the observed improvements in classification results in improvements in staining estimation. The estimation of staining of various antibodies forms the basis for localized biomarker assessment.
